Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

NCT00868491 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: docetaxel, cisplatin, 5-fluorouracil
RADIATION: radiotherapy
DRUG: cetuximab, cisplatin

Sponsor

Institute of Oncology Ljubljana